Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Slean, Geraldine R.
Khurana, Rahul N.
Stewart, Jay M.
Funding for this research was provided by:
Research to Prevent Blindness
That Man May See, Inc.